Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Service & Software > Quantitative Structure-Activity Relationship (QSAR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Quantitative Structure-Activity Relationship (QSAR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published: 2024-02-21

Pages: 84 Pages

Report ld: 2540416

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.

The global market for Quantitative Structure-Activity Relationship (QSAR) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Quantitative Structure-Activity Relationship (QSAR) include Protoqsar Sl, Intertek Group Plc, Bibra Toxicology Advice And Consulting Ltd, Covance Inc. (Labcorp), Latham Biopharm Group, Nsf International, Creative Biolabs, Qsar Lab and DassaultSystemes, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Quantitative Structure-Activity Relationship (QSAR), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Quantitative Structure-Activity Relationship (QSAR) by region & country, by Type, and by Application.

The Quantitative Structure-Activity Relationship (QSAR) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quantitative Structure-Activity Relationship (QSAR).

Market Segmentation

Report Metric
Details
Report Title
Quantitative Structure-Activity Relationship (QSAR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Market Size Available for Years
2024-2030
Global Quantitative Structure-Activity Relationship (QSAR) Companies Covered
Protoqsar Sl
Intertek Group Plc
Bibra Toxicology Advice And Consulting Ltd
Covance Inc. (Labcorp)
Latham Biopharm Group
Nsf International
Creative Biolabs
Qsar Lab
DassaultSystemes
Global Quantitative Structure-Activity Relationship (QSAR) Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Quantitative Structure-Activity Relationship (QSAR) Market, Segment by Type
Fragment Based
3D-QSAR
Chemical Descriptor Based
Global Quantitative Structure-Activity Relationship (QSAR) Market, Segment by Application
Pharmaceuticals
Cosmetics
Environmental
Food and Beverages
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Quantitative Structure-Activity Relationship (QSAR) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Quantitative Structure-Activity Relationship (QSAR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Quantitative Structure-Activity Relationship (QSAR) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Quantitative Structure-Activity Relationship (QSAR) Product Introduction
    1.2 Global Quantitative Structure-Activity Relationship (QSAR) Market Size Forecast
    1.3 Quantitative Structure-Activity Relationship (QSAR) Market Trends & Drivers
        1.3.1 Quantitative Structure-Activity Relationship (QSAR) Industry Trends
        1.3.2 Quantitative Structure-Activity Relationship (QSAR) Market Drivers & Opportunity
        1.3.3 Quantitative Structure-Activity Relationship (QSAR) Market Challenges
        1.3.4 Quantitative Structure-Activity Relationship (QSAR) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Quantitative Structure-Activity Relationship (QSAR) Players Revenue Ranking (2023)
    2.2 Global Quantitative Structure-Activity Relationship (QSAR) Revenue by Company (2019-2024)
    2.3 Key Companies Quantitative Structure-Activity Relationship (QSAR) Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Quantitative Structure-Activity Relationship (QSAR) Product Offered
    2.5 Key Companies Time to Begin Mass Production of Quantitative Structure-Activity Relationship (QSAR)
    2.6 Quantitative Structure-Activity Relationship (QSAR) Market Competitive Analysis
        2.6.1 Quantitative Structure-Activity Relationship (QSAR) Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Quantitative Structure-Activity Relationship (QSAR) Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quantitative Structure-Activity Relationship (QSAR) as of 2023)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Fragment Based
        3.1.2 3D-QSAR
        3.1.3 Chemical Descriptor Based
    3.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type
        3.2.1 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, by Type (2019-2030)
        3.2.3 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pharmaceuticals
        4.1.2 Cosmetics
        4.1.3 Environmental
        4.1.4 Food and Beverages
        4.1.5 Others
    4.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application
        4.2.1 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, by Application (2019-2030)
        4.2.3 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region
    5.1 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region
        5.1.1 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (2019-2024)
        5.1.3 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (2025-2030)
        5.1.4 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        5.2.2 North America Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        5.3.2 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        5.4.2 Asia Pacific Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        5.5.2 South America Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        5.6.2 Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Quantitative Structure-Activity Relationship (QSAR) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Quantitative Structure-Activity Relationship (QSAR) Sales Value
    6.3 United States
        6.3.1 United States Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        6.3.2 United States Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        6.4.2 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        6.5.2 China Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        6.6.2 Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        6.7.2 South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        6.8.2 Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
        6.9.2 India Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030

7 Company Profiles
    7.1 Protoqsar Sl
        7.1.1 Protoqsar Sl Profile
        7.1.2 Protoqsar Sl Main Business
        7.1.3 Protoqsar Sl Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.1.4 Protoqsar Sl Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.1.5 Protoqsar Sl Recent Developments
    7.2 Intertek Group Plc
        7.2.1 Intertek Group Plc Profile
        7.2.2 Intertek Group Plc Main Business
        7.2.3 Intertek Group Plc Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.2.4 Intertek Group Plc Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.2.5 Intertek Group Plc Recent Developments
    7.3 Bibra Toxicology Advice And Consulting Ltd
        7.3.1 Bibra Toxicology Advice And Consulting Ltd Profile
        7.3.2 Bibra Toxicology Advice And Consulting Ltd Main Business
        7.3.3 Bibra Toxicology Advice And Consulting Ltd Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.3.4 Bibra Toxicology Advice And Consulting Ltd Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.3.5 Covance Inc. (Labcorp) Recent Developments
    7.4 Covance Inc. (Labcorp)
        7.4.1 Covance Inc. (Labcorp) Profile
        7.4.2 Covance Inc. (Labcorp) Main Business
        7.4.3 Covance Inc. (Labcorp) Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.4.4 Covance Inc. (Labcorp) Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.4.5 Covance Inc. (Labcorp) Recent Developments
    7.5 Latham Biopharm Group
        7.5.1 Latham Biopharm Group Profile
        7.5.2 Latham Biopharm Group Main Business
        7.5.3 Latham Biopharm Group Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.5.4 Latham Biopharm Group Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.5.5 Latham Biopharm Group Recent Developments
    7.6 Nsf International
        7.6.1 Nsf International Profile
        7.6.2 Nsf International Main Business
        7.6.3 Nsf International Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.6.4 Nsf International Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.6.5 Nsf International Recent Developments
    7.7 Creative Biolabs
        7.7.1 Creative Biolabs Profile
        7.7.2 Creative Biolabs Main Business
        7.7.3 Creative Biolabs Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.7.4 Creative Biolabs Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.7.5 Creative Biolabs Recent Developments
    7.8 Qsar Lab
        7.8.1 Qsar Lab Profile
        7.8.2 Qsar Lab Main Business
        7.8.3 Qsar Lab Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.8.4 Qsar Lab Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.8.5 Qsar Lab Recent Developments
    7.9 DassaultSystemes
        7.9.1 DassaultSystemes Profile
        7.9.2 DassaultSystemes Main Business
        7.9.3 DassaultSystemes Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
        7.9.4 DassaultSystemes Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
        7.9.5 DassaultSystemes Recent Developments

8 Industry Chain Analysis
    8.1 Quantitative Structure-Activity Relationship (QSAR) Industrial Chain
    8.2 Quantitative Structure-Activity Relationship (QSAR) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Quantitative Structure-Activity Relationship (QSAR) Sales Model
        8.5.2 Sales Channel
        8.5.3 Quantitative Structure-Activity Relationship (QSAR) Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Quantitative Structure-Activity Relationship (QSAR) Market Trends
    Table 2. Quantitative Structure-Activity Relationship (QSAR) Market Drivers & Opportunity
    Table 3. Quantitative Structure-Activity Relationship (QSAR) Market Challenges
    Table 4. Quantitative Structure-Activity Relationship (QSAR) Market Restraints
    Table 5. Global Quantitative Structure-Activity Relationship (QSAR) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Quantitative Structure-Activity Relationship (QSAR) Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Quantitative Structure-Activity Relationship (QSAR) Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Quantitative Structure-Activity Relationship (QSAR) Product Type
    Table 9. Key Companies Time to Begin Mass Production of Quantitative Structure-Activity Relationship (QSAR)
    Table 10. Global Quantitative Structure-Activity Relationship (QSAR) Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quantitative Structure-Activity Relationship (QSAR) as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Quantitative Structure-Activity Relationship (QSAR) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Quantitative Structure-Activity Relationship (QSAR) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Quantitative Structure-Activity Relationship (QSAR) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Quantitative Structure-Activity Relationship (QSAR) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (2019-2024) & (%)
    Table 27. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Quantitative Structure-Activity Relationship (QSAR) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2025-2030) & (US$ Million)
    Table 31. Protoqsar Sl Basic Information List
    Table 32. Protoqsar Sl Description and Business Overview
    Table 33. Protoqsar Sl Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of Protoqsar Sl (2019-2024)
    Table 35. Protoqsar Sl Recent Developments
    Table 36. Intertek Group Plc Basic Information List
    Table 37. Intertek Group Plc Description and Business Overview
    Table 38. Intertek Group Plc Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of Intertek Group Plc (2019-2024)
    Table 40. Intertek Group Plc Recent Developments
    Table 41. Bibra Toxicology Advice And Consulting Ltd Basic Information List
    Table 42. Bibra Toxicology Advice And Consulting Ltd Description and Business Overview
    Table 43. Bibra Toxicology Advice And Consulting Ltd Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of Bibra Toxicology Advice And Consulting Ltd (2019-2024)
    Table 45. Bibra Toxicology Advice And Consulting Ltd Recent Developments
    Table 46. Covance Inc. (Labcorp) Basic Information List
    Table 47. Covance Inc. (Labcorp) Description and Business Overview
    Table 48. Covance Inc. (Labcorp) Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of Covance Inc. (Labcorp) (2019-2024)
    Table 50. Covance Inc. (Labcorp) Recent Developments
    Table 51. Latham Biopharm Group Basic Information List
    Table 52. Latham Biopharm Group Description and Business Overview
    Table 53. Latham Biopharm Group Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of Latham Biopharm Group (2019-2024)
    Table 55. Latham Biopharm Group Recent Developments
    Table 56. Nsf International Basic Information List
    Table 57. Nsf International Description and Business Overview
    Table 58. Nsf International Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of Nsf International (2019-2024)
    Table 60. Nsf International Recent Developments
    Table 61. Creative Biolabs Basic Information List
    Table 62. Creative Biolabs Description and Business Overview
    Table 63. Creative Biolabs Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of Creative Biolabs (2019-2024)
    Table 65. Creative Biolabs Recent Developments
    Table 66. Qsar Lab Basic Information List
    Table 67. Qsar Lab Description and Business Overview
    Table 68. Qsar Lab Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of Qsar Lab (2019-2024)
    Table 70. Qsar Lab Recent Developments
    Table 71. DassaultSystemes Basic Information List
    Table 72. DassaultSystemes Description and Business Overview
    Table 73. DassaultSystemes Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Quantitative Structure-Activity Relationship (QSAR) Business of DassaultSystemes (2019-2024)
    Table 75. DassaultSystemes Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Quantitative Structure-Activity Relationship (QSAR) Downstream Customers
    Table 79. Quantitative Structure-Activity Relationship (QSAR) Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Quantitative Structure-Activity Relationship (QSAR) Product Picture
    Figure 2. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Quantitative Structure-Activity Relationship (QSAR) Report Years Considered
    Figure 5. Global Quantitative Structure-Activity Relationship (QSAR) Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Quantitative Structure-Activity Relationship (QSAR) Revenue in 2023
    Figure 7. Quantitative Structure-Activity Relationship (QSAR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Fragment Based Picture
    Figure 9. 3D-QSAR Picture
    Figure 10. Chemical Descriptor Based Picture
    Figure 11. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Pharmaceuticals
    Figure 14. Product Picture of Cosmetics
    Figure 15. Product Picture of Environmental
    Figure 16. Product Picture of Food and Beverages
    Figure 17. Product Picture of Others
    Figure 18. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Quantitative Structure-Activity Relationship (QSAR) Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Quantitative Structure-Activity Relationship (QSAR) Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Quantitative Structure-Activity Relationship (QSAR) Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Quantitative Structure-Activity Relationship (QSAR) Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Quantitative Structure-Activity Relationship (QSAR) Sales Value (%), (2019-2030)
    Figure 31. United States Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Quantitative Structure-Activity Relationship (QSAR) Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (%), 2023 VS 2030
    Figure 52. Quantitative Structure-Activity Relationship (QSAR) Industrial Chain
    Figure 53. Quantitative Structure-Activity Relationship (QSAR) Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

Description

QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.

The global market for Quantitative Structure-Activity Relationship (QSAR) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Quantitative Structure-Activity Relationship (QSAR) include Protoqsar Sl, Intertek Group Plc, Bibra Toxicology Advice And Consulting Ltd, Covance Inc. (Labcorp), Latham Biopharm Group, Nsf International, Creative Biolabs, Qsar Lab and DassaultSystemes, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Quantitative Structure-Activity Relationship (QSAR), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Quantitative Structure-Activity Relationship (QSAR) by region & country, by Type, and by Application.

The Quantitative Structure-Activity Relationship (QSAR) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quantitative Structure-Activity Relationship (QSAR).

Market Segmentation

Related Reports

Global Quantitative Structure-Activity Relationship (QSAR) Market Research Report 2024
QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.
Published: 2024-01-17
Pages: 75
USD 2900.00
(Single User License)
Global Quantitative Structure-Activity Relationship (QSAR) Market Insights, Forecast to 2030
QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.
Published: 2024-04-16
Pages: 92
USD 4900.00
(Single User License)
Global Quantitative Structure-Activity Relationship (QSAR) Market Research Report 2025
The global market for Quantitative Structure-Activity Relationship (QSAR) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 75
USD 2900.00
(Single User License)
Quantitative Structure-Activity Relationship (QSAR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Quantitative Structure-Activity Relationship (QSAR) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 81
USD 3950.00
(Single User License)
Global Quantitative Structure-Activity Relationship (QSAR) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Quantitative Structure-Activity Relationship (QSAR) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 76
USD 4250.00
(Single User License)
Global Quantitative Structure-Activity Relationship (QSAR) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Quantitative Structure-Activity Relationship (QSAR) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 124
USD 4900.00
(Single User License)

Global Quantitative Structure-Activity Relationship (QSAR) Market Research Report 2024
QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.
Published: 2024-01-17
Pages: 75
USD 2900.00 ()
Global Quantitative Structure-Activity Relationship (QSAR) Market Insights, Forecast to 2030
QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.
Published: 2024-04-16
Pages: 92
USD 4900.00 ()
Global Quantitative Structure-Activity Relationship (QSAR) Market Research Report 2025
The global market for Quantitative Structure-Activity Relationship (QSAR) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 75
USD 2900.00 ()
Quantitative Structure-Activity Relationship (QSAR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Quantitative Structure-Activity Relationship (QSAR) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 81
USD 3950.00 ()
Global Quantitative Structure-Activity Relationship (QSAR) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Quantitative Structure-Activity Relationship (QSAR) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 76
USD 4250.00 ()
Global Quantitative Structure-Activity Relationship (QSAR) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Quantitative Structure-Activity Relationship (QSAR) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 124
USD 4900.00 ()